<i>BRCA</i> Mutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 31038410.
- Also identified by DOI 10.1148/radiol.2019181814.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients who carry the <i>BRCA</i>1 and <i>BRCA</i>2 gene mutations have an underlying genetic predisposition for breast and ovarian cancers. These deleterious genetic mutations are the most common genes implicated in hereditary breast and ovarian cancers. This monograph summarizes the evidence behind current screening recommendations, reviews imaging protocols specific to this patient population, and illustrates some of the imaging nuances of breast and ovarian cancers in this clinical setting.
Medical subject headings
- BRCA1 Protein
- BRCA2 Protein
- Breast Neoplasms
- Early Detection of Cancer
- Ovarian Neoplasms